164 related articles for article (PubMed ID: 38140130)
1. Preparation of
Liu N; Xiao J; Zang LH; Quan P; Liu DC
Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140130
[TBL] [Abstract][Full Text] [Related]
2. Release Characteristics of an Essential Oil Component Encapsulated with Cyclodextrin Shell Matrices.
Li Z; Wen W; Chen X; Zhu L; Cheng G; Liao Z; Huang H; Ming L
Curr Drug Deliv; 2021; 18(4):487-499. PubMed ID: 32735520
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
Patel SG; Rajput SJ
AAPS PharmSciTech; 2009; 10(2):660-9. PubMed ID: 19459053
[TBL] [Abstract][Full Text] [Related]
4. Preparation, Characterization, and Bioavailability of Host-Guest Inclusion Complex of Ginsenoside Re with Gamma-Cyclodextrin.
Li H; Zhang G; Wang W; Chen C; Jiao L; Wu W
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885811
[TBL] [Abstract][Full Text] [Related]
5. Development of morin/hydroxypropyl-β-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects.
Lima BDS; Campos CA; da Silva Santos ACR; Santos VCN; Trindade GDGG; Shanmugam S; Pereira EWM; Marreto RN; Duarte MC; Almeida JRGDS; Quintans JSS; Quintans LJ; Araújo AAS
Food Chem Toxicol; 2019 Apr; 126():15-24. PubMed ID: 30738132
[TBL] [Abstract][Full Text] [Related]
6. Preparation, Characterization, and Properties of Inclusion Complexes of Balofloxacin with Cyclodextrins.
Ren X; Qian H; Tang P; Tang Y; Liu Y; Pu H; Zhang M; Zhao L; Li H
AAPS PharmSciTech; 2019 Aug; 20(7):278. PubMed ID: 31396732
[TBL] [Abstract][Full Text] [Related]
7. Molecular Encapsulation of Cinnamaldehyde within Cyclodextrin Inclusion Complex Electrospun Nanofibers: Fast-Dissolution, Enhanced Water Solubility, High Temperature Stability, and Antibacterial Activity of Cinnamaldehyde.
Yildiz ZI; Kilic ME; Durgun E; Uyar T
J Agric Food Chem; 2019 Oct; 67(40):11066-11076. PubMed ID: 31508948
[TBL] [Abstract][Full Text] [Related]
8. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
9. Preparation and Properties of Cyclodextrin Inclusion Complexes of
Zhang X; Su J; Wang X; Wang X; Liu R; Fu X; Li Y; Xue J; Li X; Zhang R; Chu X
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566111
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
11. Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems.
Lahiani-Skiba M; Barbot C; Bounoure F; Joudieh S; Skiba M
Drug Dev Ind Pharm; 2006 Oct; 32(9):1043-58. PubMed ID: 17012117
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
Desai C; Prabhakar B
Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555
[TBL] [Abstract][Full Text] [Related]
13. Solid inclusion complexes of vanillin with cyclodextrins: their formation, characterization, and high-temperature stability.
Kayaci F; Uyar T
J Agric Food Chem; 2011 Nov; 59(21):11772-8. PubMed ID: 21928857
[TBL] [Abstract][Full Text] [Related]
14. Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation.
Chi L; Liu R; Guo T; Wang M; Liao Z; Wu L; Li H; Wu D; Zhang J
Int J Pharm; 2015 Feb; 479(2):349-56. PubMed ID: 25575474
[TBL] [Abstract][Full Text] [Related]
15. Complexation of phenytoin with some hydrophilic cyclodextrins: effect on aqueous solubility, dissolution rate, and anticonvulsant activity in mice.
Latrofa A; Trapani G; Franco M; Serra M; Muggironi M; Fanizzi FP; Cutrignelli A; Liso G
Eur J Pharm Biopharm; 2001 Jul; 52(1):65-73. PubMed ID: 11438425
[TBL] [Abstract][Full Text] [Related]
16. Inclusion Complexes of Hydroxy Propyl-β-Cyclodextrin and Paliperidone: Preparation and Characterization.
Sherje A; Londhe V
Curr Drug Discov Technol; 2014; 11(4):271-8. PubMed ID: 25578059
[TBL] [Abstract][Full Text] [Related]
17. Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation.
Yousaf AM; Kim DW; Oh YK; Yong CS; Kim JO; Choi HG
Int J Nanomedicine; 2015; 10():1819-30. PubMed ID: 25784807
[TBL] [Abstract][Full Text] [Related]
18. Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics.
Chauhan R; Madan J; Kaushik D; Sardana S; Pandey RS; Sharma R
Pharm Dev Technol; 2013; 18(2):313-22. PubMed ID: 21699389
[TBL] [Abstract][Full Text] [Related]
19. The formation of an inclusion complex between a metabolite of ginsenoside, compound K and γ-cyclodextrin and its dissolution characteristics.
Igami K; Ozawa M; Inoue S; Iohara D; Miyazaki T; Shinoda M; Anraku M; Hirayama F; Uekama K
J Pharm Pharmacol; 2016 May; 68(5):646-54. PubMed ID: 26255976
[TBL] [Abstract][Full Text] [Related]
20. Effect of preparation processes and structural insight into the supermolecular system: Bisacodyl and β-cyclodextrin inclusion complex.
Li S; Zhai Y; Yan J; Wang L; Xu K; Li H
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():224-32. PubMed ID: 26478306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
